A Relative Bioavailability and Food-Effect Study of the Fixed Dose Combination of GSK3640254 and Dolutegravir (DTG) in Healthy Participants
Clinical trial NCT04857892 · COMPLETED
Trial details
- NCT number
- NCT04857892
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-21
- Primary completion
- 2021-09-10
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.